ANTI-FCRN ANTIBODIES

The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.

Saved in:
Bibliographic Details
Main Authors CHRISTOPH MEIER, KAUSHIK SARKAR, PAUL ALAN ATHERFOLD, ALASTAIR DAVID GRIFFITHS LAWSON, LARA KEVORKIAN, HELENE MARGARET FINNEY, STEVAN GRAHAM SHAW, BRYAN JOHN SMITH, KERRY LOUISE TYSON
Format Patent
LanguageEnglish
Portuguese
Published 23.07.2019
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA.
Bibliography:Application Number: PT20130725298T